Ann: Zantrene highly effective in EMD AML Mouse Model, page-76

For all those worrying about their investment and others that want to troll rac.

1. fully funded to execute their plans.
2. Small number of shares on issue, in the investing space, this is a huge advantage.
3. On track to deliver results on time and on budget.
4. The top shareholders are directors with their own $$ invested, again this is another big advantage.
5. Well run, well organised, highly skilled and competent, again, this is another huge advantage.
6. Have the most clinically mature cancer drug innn no the aust boitech space, again, huge advantage.
7. The cardioprotective results put rac in an unbelievable position to enter a clinically mature market very quickly.
8. Have a clear well defined plan that will help deliver an incredible drug to the oncology space in a very short space of time.

Be patient, research and enjoy the ride, it’s about to get interesting.

DYOR